While vaccination has proven to be an effective strategy to prevent Covid-19, the need exists for inexpensive, room-temperature stable, and […]
Category: Uncategorized
TUBE Pharmaceuticals and MolGenie collaborate
TUBE Pharmaceuticals GmbH in Vienna, Austria, has developed cytotoxic molecules that are derived from a class of natural products called […]
MolGenie develops new peptide-drug-conjugates (PDC)
MolGenie has currently been assigned the rights to develop and commercialize the rights to a EU-PCT patent application claiming treatments […]
OntoChem Assigns Anixa Covid-19 Drug Discovery Project to MolGenie
HALLE (SAALE), Germany, May 7, 2021 /PRNewswire/ — OntoChem GmbH, a German Life Science IT company, announced today that it has assigned its drug […]
New ADC approval
On April 23, 2021, the Food and Drug Administration approved loncastuximab tesirine-lpyl (Zynlonta, ADC Therapeutics SA), a CD19-directed antibody and […]